Compounding Pharmacy Meningitis Outbreak Caused 61 Deaths, 749 Infections, Study Says

An official analysis of the September 2012 fungal meningitis outbreak connected to injections of methylprednisolone acetate from a compounding pharmacy has found it caused 61 deaths and 749 incident-related infections, according to a study in The New England Journal of Medicine.

Advertisement

The study examined clinical data from case report forms and tested for the fungi in available specimens.

Read the full article on Becker’s ASC Review.

More Articles on Quality:

The Infection Control Round-Up: 10 Major Stories From the Last Half of 2013

NQCA’s State of Healthcare Report Mostly Positive, Has Record Amounts of Data

Leapfrog Releases Fall 2013 Hospital Grades

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.